Technology
Health
Pharmaceutical

Athenex

1,410

$11.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (+0.85%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours

Why Robinhood?

You can buy or sell Athenex and other stocks, options, ETFs, and crypto commission-free!

About ATNX

Athenex, Inc. Common Stock, also called Athenex, is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer.It operates through the following segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. Read More The Oncology Innovation Platform segment involves in discovery and development of cancer supportive therapies. The Global Supply Chain Platform segment consists of manufacturing and marketing of API, medical devices, and clinical products. The Commercial Platform segment engages in manufacturing and selling of commercial pharmaceutical products. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.

CEO
Yiu Nam Lau
Employees
582
Headquarters
Buffalo, New York
Founded
2003
Market Cap
905.10M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
582.90K
High Today
$12.03
Low Today
$11.67
Open Price
$11.97
Volume
483.52K
52 Week High
$21.11
52 Week Low
$8.82

Collections

Technology
Health
Pharmaceutical
Cancer Prevention
Biopharmaceutical
Medical
Manufacturing
Advertising and Marketing

ATNX News

ReutersNov 8

Edited Transcript of ATNX earnings conference call or presentation 7-Nov-19 1:00pm GMT

Q3 2019 Athenex Inc Earnings Call BUFFALO Nov 8, 2019 (Thomson StreetEvents) -- Edited Transcript of Athenex Inc earnings conference call or presentation Thurs
32

ATNX Earnings

-$0.58
-$0.41
-$0.24
-$0.07
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
-$0.45 per share
Actual
-$0.45 per share
Replay Earnings Call

You May Also Like

DSKE
SNCR
PIC+
QRHC
GNL
GSEU
AWCMY
JMUB
AGT
ADBE
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ATNX

Market Price$11.81
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Athenex stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up